Vernieri, F., Brunelli, N., Marcosano, M., Aurilia, C., Egeo, G., Lovati, C., Favoni, V., Perrotta, A., Maestrini, I., Rao, R., d'Onofrio, L., Finocchi, C., Aguggia, M., Bono, F., Ranieri, A., Albanese, M., Di Piero, V., Cevoli, S., Altamura, C., Barbanti, P., & , (2023). maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study. European journal of neurology, 30, 224–234. http://access.bl.uk/ark:/81055/vdc_100172533440.0x000037